Creotech Instruments SA
F:5OB
Balance Sheet
Balance Sheet Decomposition
Creotech Instruments SA
Creotech Instruments SA
Balance Sheet
Creotech Instruments SA
| Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Cash & Cash Equivalents |
3
|
6
|
12
|
26
|
73
|
0
|
|
| Cash |
3
|
6
|
12
|
26
|
73
|
0
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
5
|
6
|
8
|
10
|
13
|
13
|
|
| Accounts Receivables |
4
|
5
|
7
|
5
|
6
|
0
|
|
| Other Receivables |
1
|
1
|
1
|
5
|
6
|
0
|
|
| Inventory |
2
|
1
|
5
|
9
|
10
|
9
|
|
| Other Current Assets |
6
|
10
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
16
|
23
|
24
|
45
|
95
|
55
|
|
| PP&E Net |
2
|
5
|
7
|
7
|
33
|
33
|
|
| PP&E Gross |
0
|
0
|
0
|
7
|
33
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
4
|
8
|
0
|
|
| Intangible Assets |
3
|
2
|
13
|
21
|
36
|
50
|
|
| Note Receivable |
1
|
0
|
0
|
0
|
3
|
15
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
1
|
2
|
5
|
0
|
|
| Total Assets |
21
N/A
|
31
+43%
|
46
+50%
|
75
+64%
|
173
+129%
|
162
-6%
|
|
| Liabilities | |||||||
| Accounts Payable |
5
|
6
|
5
|
10
|
21
|
22
|
|
| Accrued Liabilities |
4
|
9
|
2
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
2
|
3
|
5
|
1
|
2
|
2
|
|
| Other Current Liabilities |
4
|
4
|
1
|
2
|
2
|
5
|
|
| Total Current Liabilities |
15
|
21
|
13
|
13
|
24
|
30
|
|
| Long-Term Debt |
0
|
1
|
0
|
2
|
22
|
20
|
|
| Deferred Income Tax |
0
|
0
|
1
|
0
|
0
|
0
|
|
| Other Liabilities |
1
|
1
|
14
|
12
|
35
|
42
|
|
| Total Liabilities |
16
N/A
|
23
+47%
|
28
+18%
|
27
-3%
|
81
+202%
|
91
+12%
|
|
| Equity | |||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
3
|
1
|
1
|
8
|
15
|
21
|
|
| Additional Paid In Capital |
8
|
8
|
19
|
56
|
106
|
92
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
5
N/A
|
7
+33%
|
18
+153%
|
48
+166%
|
91
+88%
|
71
-22%
|
|
| Total Liabilities & Equity |
21
N/A
|
31
+43%
|
46
+50%
|
75
+64%
|
173
+129%
|
162
-6%
|
|
| Shares Outstanding | |||||||
| Common Shares Outstanding |
2
|
2
|
2
|
2
|
2
|
2
|
|